Abstract
Antimicrobial resistance is a global public health concern. Hospitals in developing countries are fighting a progressively uphill battle against not only high burden of infectious diseases but also an ever-increasing proportion of multidrug-resistant pathogens. As many as 56% of Staphylococcus aureus isolates from hospital-acquired infections in South Asia have now become methicillin resistant. Vancomycin-resistant enterococci (VRE), with a reported prevalence of 6–12% in Asian hospital-based studies account for 10% of nosocomial urinary tract infections and a 31% mortality rate with VRE bacteremias. Third-generation cephalosporin-resistant Escherichia coli and Klebsiella account for case fatality rates between 12 and 52% in neonatal inpatients. Pan-resistance has been reported in 14–35.8% isolates of Acinetobacter spp. from developing country hospital inpatients over the last decade. Pseudomonas spp., an important neonatal killer in the Indo-Pak subcontinent, is ceftazidime resistant in 34–55% isolates and aminoglycoside resistant in 23–69% isolates. Alarmingly, these figures show a rising temporal trend and highlight antimicrobial-resistant organisms as major, untreatable threats in many resource-constrained countries. Antimicrobial resistance does not only mean increasing expense of treatment and poor clinical outcomes but also has a major impact on the way health systems are perceived and therefore accessed. There is an urgent need to devise comprehensive strategies and programs for improving hospital infection control and containing antimicrobial resistance in developing countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Otaibi, F.E., Kambal, A.M., and Baabbad, R.A. 2004. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia. Saudi. Med. J. 25: 21–25.
Alp, E., Esel, D., Yildiz, O., Voss, A., Melchers, W., and Doganay, M. 2006. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Scand. J. Infect. Dis. 38: 335–340.
Archibald, L.K. and Reller, L.B. 2001. Clinical microbiology in developing countries. Emerg. Infect. Dis. 7: 302–305.
Austin, D.J., Bonten, M.J., Weinstein, R.A., Slaughter, S., and Anderson, R.M. 1999. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl. Acad. Sci. U.S.A 96: 6908–6913.
Baddour, M.M., Abuelkheir, M.M., Fatani, A.J., Bohol, M.F., and Al-Ahdal, M.N. 2007. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from major hospitals in Riyadh, Saudi Arabia. Can. J. Microbiol. 53: 931–936.
Balkhy, H.H., Cunningham, G., Chew, F.K., Francis, C., Al Nakhli, D.J., Almuneef, M.A., and Memish, Z.A. 2006. Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int. J. Infect. Dis. 10: 326–333.
Bartoloni, A., Cutts, F., Leoni, S., Austin, C.C., Mantella, A., Guglielmetti, P., Roselli, M., Salazar, E., and Paradisi, F. 1998. Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop. Med. Int. Health 3: 116–123.
Bello, H., Dominguez, M., Gonzalez, G., Zemelman, R., Mella, S., Young, H.K., and Amyes, S.G. 2000. In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998. J. Antimicrob. Chemother. 45: 712–713.
Bexell, A., Lwando, E., von, H.B., Tembo, S., Eriksson, B., and Diwan, V.K. 1996. Improving drug use through continuing education: a randomized controlled trial in Zambia. J. Clin. Epidemiol. 49: 355–357.
Boyce, J.M. 2007. Environmental contamination makes an important contribution to hospital infection. J. Hosp. Infect. 65 Suppl 2: 50–54.
Brusaferro, S., Regattin, L., Faruzzo, A., Grasso, A., Basile, M., Calligaris, L., Scudeller, L., and Viale, P. 2006. Surveillance of hospital-acquired infections: a model for settings with resource constraints. Am. J. Infect. Control 34: 362–366.
Coen, P.G. 2007. How mathematical models have helped to improve understanding the epidemiology of infection. Early Hum. Dev. 83: 141–148.
d'Azevedo, P.A., Dias, C.A., and Teixeira, L.M. 2006. Genetic diversity and antimicrobial resistance of enterococcal isolates from Southern region of Brazil. Rev. Inst. Med. Trop. Sao Paulo 48: 11–16.
de Allori, M.C., Jure, M.A., Romero, C., and de Castillo, M.E. 2006. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol. Pharm. Bull. 29: 1592–1596.
Desta, Z., Abula, T., Beyene, L., Fantahun, M., Yohannes, A.G., and Ayalew, S. 1997. Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia. East Afr. Med. J. 74: 758–763.
Dimond, B. 2006. Infection control: the rights of the patient. Br. J. Nurs. 15: 670–671.
Dineshkumar, B., Raghuram, T.C., Radhaiah, G., and Krishnaswamy, K. 1995. Profile of drug use in urban and rural India. Pharmacoeconomics 7: 332–346.
Duttaroy, B. and Mehta, S. 2005. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J. Pathol. Microbiol. 48: 45–48.
Ejilemele, A.A. and Ojule, A.C. 2005. Knowledge, attitude and practice of aspects of laboratory safety in Pathology Laboratories at the University of Port Harcourt Teaching Hospital, Nigeria. Niger. J. Clin. Pract. 8: 102–106.
Gaudiano, M.C., Di, M.A., Cocchieri, E., Antoniella, E., Bertocchi, P., Alimonti, S., and Valvo, L. 2007. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. Malar. J. 6: 22.
Geyid, A. and Lemeneh, Y. 1991. The incidence of methicillin resistant S. aureus strains in clinical specimens in relation to their beta-lactamase producing and multiple-drug resistance properties in Addis Abeba. Ethiop. Med. J. 29: 149–161.
Grover, S.S., Sharma, M., Chattopadhya, D., Kapoor, H., Pasha, S.T., and Singh, G. 2006. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J. Infect. 53: 279–288.
Haddad, Q., Sobayo, E.I., Basit, O.B., and Rotimi, V.O. 1993. Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. J. Hosp. Infect. 23: 211–222.
Hanssens, Y., Ismaeil, B.B., Kamha, A.A., Elshafie, S.S., Adheir, F.S., Saleh, T.M., and Deleu, D. 2005. Antibiotic prescribing pattern in a medical intensive care unit in Qatar. Saudi. Med. J. 26: 1269–1276.
Harris, A.D., Perencevich, E.N., Johnson, J.K., Paterson, D.L., Morris, J.G., Strauss, S.M., and Johnson, J.A. 2007. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin. Infect. Dis. 45: 1347–1350.
Hart, C.A. and Kariuki, S. 1998. Antimicrobial resistance in developing countries. BMJ 317: 647–650.
Harvey, K., Kalanj, K., and Stevanovic, R. 2004. Croatian pharmaceutical sector reform project: rational drug use. Croat. Med. J. 45: 611–619.
Hogerzeil, H.V., Bimo, Ross-Degnan, D., Laing, R.O., Ofori-Adjei, D., Santoso, B., zad Chowdhury, A.K., Das, A.M., Kafle, K.K., Mabadeje, A.F., et al.. 1993. Field tests for rational drug use in twelve developing countries. Lancet 342: 1408–1410.
Jarvis, W.R. 2003. Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience. Infection 31 Suppl 2: 44–48.
Jeena, P., Thompson, E., Nchabeleng, M., and Sturm, A. 2001. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann. Trop. Paediatr. 21: 245–251.
Jroundi, I., Khoudri, I., Azzouzi, A., Zeggwagh, A.A., Benbrahim, N.F., Hassouni, F., Oualine, M., and Abouqal, R. 2007. Prevalence of hospital-acquired infection in a Moroccan university hospital. Am. J. Infect. Control 35: 412–416.
Kanafani, Z.A., Kara, L., Hayek, S., and Kanj, S.S. 2003. Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect. Control Hosp. Epidemiol. 24: 864–869.
Kaushik, S.L., Parmar, V.R., Grover, N., Grover, P.S., and Kaushik, R. 1998. Neonatal sepsis in hospital born babies. J. Commun. Dis. 30: 147–152.
Kesah, C., Ben, R.S., Odugbemi, T.O., Boye, C.S., Dosso, M., Ndinya Achola, J.O., Koulla-Shiro, S., Benbachir, M., Rahal, K., and Borg, M. 2003. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin. Microbiol. Infect. 9: 153–156.
Kim, P.W., Roghmann, M.C., Perencevich, E.N., and Harris, A.D. 2003. Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites. Am. J. Infect. Control 31: 97–103.
Krishnan, P.U., Mahalakshmi, P., and Shetty, N. 2002. Strain relatedness of endemic MRSA isolates in a burns unit in South India––a five year study. J.Hosp.Infect. 52: 181–184.
Leblebicioglu, H., Rosenthal, V.D., Arikan, O.A., Ozgultekin, A., Yalcin, A.N., Koksal, I., Usluer, G., Sardan, Y.C., and Ulusoy, S. 2007. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J. Hosp. Infect. 65: 251–257.
Lopes, J.M., Starling, C.E., Lessa, C., and Couto, B.R. 1999. Joint effort to improve quality in a Brazilian pediatric public hospital through cross-infection control. J. Pediatr. (Rio J. ) 75: 361–366.
Macias, A.E., Munoz, J.M., Herrera, L.E., Medina, H., Hernandez, I., Alcantar, D., and Ponce de, L.S. 2004. Nosocomial pediatric bacteremia: the role of intravenous set contamination in developing countries. Infect. Control Hosp. Epidemiol. 25: 226–230.
Macias, A.E. and Ponce-de-Leon, S. 2005. Infection control: old problems and new challenges. Arch. Med. Res. 36: 637–645.
Mallet, H.P., Njikam, A., and Scouflaire, S.M. 2001. Evaluation of prescription practices and of the rational use of medicines in Niger. Sante 11: 185–193.
Mayon-White, R.T., Ducel, G., Kereselidze, T., and Tikomirov, E. 1988. An international survey of the prevalence of hospital-acquired infection. J. Hosp. Infect. 11 Suppl A: 43–48.
Meric, M., Willke, A., Caglayan, C., and Toker, K. 2005. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn. J. Infect. Dis. 58: 297–302.
Misbah, S., AbuBakar, S., Hassan, H., Hanifah, Y.A., and Yusof, M.Y. 2004. Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart. J. Hosp. Infect. 58: 254–261.
Mohanty, S., Singhal, R., Sood, S., Dhawan, B., Kapil, A., and Das, B.K. 2007. Citrobacter infections in a tertiary care hospital in Northern India. J. Infect. 54: 58–64.
Murray, B.E. 1992. Problems and dilemmas of antimicrobial resistance. Pharmacotherapy 12: 86S–93S.
Naeem, I., Naqvi, B.S., Hashmi, K., and Gauhar, S. 2006. Paediatric nosocomial infections: resistance pattern of clinical isolates. Pak. J. Pharm. Sci. 19: 52–57.
Nathoo, K.J., Mason, P.R., and Chimbira, T.H. 1990. Neonatal septicaemia in Harare Hospital: aetiology and risk factors. The Puerperal Sepsis Study Group. Cent. Afr. J. Med. 36: 150–156.
Norazah, A., Lim, V.K., Rohani, M.Y., Alfizah, H., Koh, Y.T., and Kamel, A.G. 2003. A major methicillin-resistant Staphylococcus aureus clone predominates in Malaysian hospitals. Epidemiol. Infect. 130: 407–411.
Nyamogoba, H. and Obala, A.A. 2002. Nosocomial infections in developing countries: cost effective control and prevention. East Afr. Med. J. 79: 435–441.
Oncul, O., Yuksel, F., Altunay, H., Acikel, C., Celikoz, B., and Cavuslu, S. 2002. The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. Burns 28: 738–744.
Orrett, F.A. 2005. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad. Saudi. Med. J. 26: 1766–1770.
Ota, R., Takahashi, C., Shiraishi, T., and Tominaga, M. 2007. Genesis of methicillin-resistant Staphylococcus aureus and selective antibacterial injection pressure. Kansenshogaku Zasshi 81: 370–378.
Panknin, H.T. 2006. Prevention of ventilator-associated pneumonia: review of national and international guidelines. Pflege. Z. 59: suppl-8.
Pearse, J. 1997. Infection control in Africa. Nosocomial infection. Afr. Health 19: 10–11.
Perdelli, F., Dallera, M., Cristina, M.L., Sartini, M., Ottria, G., Spagnolo, A.M., and Orlando, P. 2007. A new microbiological problem in intensive care units: environmental contamination by MRSA with reduced susceptibility to glycopeptides. Int. J. Hyg. Environ. Health 211(1–2):213–218.
Perovic, O., Koornhof, H., Black, V., Moodley, I., Duse, A., and Galpin, J. 2006. Staphylococcus aureus bacteraemia at two academic hospitals in Johannesburg. S. Afr. Med. J. 96: 714–717.
Perwaiz, S., Barakzi, Q., Farooqi, B.J., Khursheed, N., and Sabir, N. 2007. Antimicrobial susceptibility pattern of clinical isolates of methicillin resistant Staphylococcus aureus. J. Pak. Med. Assoc. 57: 2–4.
Ponce-de-Leon, S. 1991. The needs of developing countries and the resources required. J. Hosp. Infect. 18 Suppl A: 376–381.
Pottinger J.M., Herwaldt L.A., and Perl T.M. 1998. Basics of Surveillance-an overview. In A Practical Handbook for Hospital Epidemiologists. The Society for Healthcare Epidemiology of America. SLACK Incorporated and SHEA.
Prashanth, K. and Badrinath, S. 2005. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis. Indian J. Med. Res. 122: 408–418.
Qadri, S.M., Huber, T.W., Lee, G.C., and al-Hajjar, S. 1994. Antimicrobial resistance of bacterial pathogens at two tertiary-care centers, in Riyadh and Texas. Tex. Med. 90: 59–62.
Ramdani-Bouguessa, N., Bes, M., Meugnier, H., Forey, F., Reverdy, M.E., Lina, G., Vandenesch, F., Tazir, M., and Etienne, J. 2006. Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob. Agents Chemother. 50: 1083–1085.
Rhinehart, E., Goldmann, D.A., and O'Rourke, E.J. 1991. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am. J. Med. 91: 213S–220S.
Ribas, R.M., Freitas, C., and Gontijo Filho, P.P. 2007. Nosocomial bloodstream infections: organisms, risk factors and resistant phenotypes in the Brazilian University Hospital. Braz. J. Infect. Dis. 11: 351–354.
Romero, D.V., Treston, J., and O'Sullivan, A.L. 2006. Hand-to-hand combat: preventing MRSA infection. Adv. Skin Wound Care 19: 328–33, quiz.
Rosenthal, V.D., Guzman, S., and Orellano, P.W. 2003. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am. J. Infect. Control 31: 291–295.
Rosenthal, V.D., Maki, D.G., Salomao, R., Moreno, C.A., Mehta, Y., Higuera, F., Cuellar, L.E., Arikan, O.A., Abouqal, R., and Leblebicioglu, H. 2006. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann. Intern. Med. 145: 582–591.
Saez-Llorens, X., Castrejon de Wong, M.M., Castano, E., De, S.O., De, M.D., and De, A., I .2000. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr. Infect. Dis. J. 19: 200–206.
Safdar, N. and Maki, D.G. 2002. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136: 834–844.
Selgelid, M.J. 2005. Ethics and infectious disease. Bioethics 19: 272–289.
Shehabi, A.A., Mahafzah, A.M., and Al-Khalili, K.Z. 2004. Antimicrobial resistance and plasmid profiles of urinary Escherichia coli isolates from Jordanian patients. East Mediterr. Health J. 10: 322–328.
Soleto, L., Pirard, M., Boelaert, M., Peredo, R., Vargas, R., Gianella, A., and Van der, S.P. 2003. Incidence of surgical-site infections and the validity of the National Nosocomial Infections Surveillance System risk index in a general surgical ward in Santa Cruz, Bolivia. Infect. Control Hosp. Epidemiol. 24: 26–30.
Szeto, C.C., Chow, K.M., Kwan, B.C., Law, M.C., Chung, K.Y., Yu, S., Leung, C.B., and Li, P.K. 2007. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin. J. Am. Soc. Nephrol. 2: 245–251.
Tateda, K. 2002. From the perspective of clinical laboratory physicians. Rinsho Byori 50: 672–677.
Torres, A. 2006. The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information. Curr. Opin. Crit. Care 12(5):444–445.
Urdea, M., Penny, L.A., Olmsted, S.S., Giovanni, M.Y., Kaspar, P., Shepherd, A., Wilson, P., Dahl, C.A., Buchsbaum, S., Moeller, G., and Hay, B. 2006. Requirements for high impact diagnostics in the developing world. Nature 444 Suppl 1: 73–79.
Vidhani, S., Mehndiratta, P.L., and Mathur, M.D. 2001. Study of methicillin resistant S. aureus (MRSA) isolates from high risk patients. Indian J. Med. Microbiol. 19: 13–16.
vila-Figueroa, C., Cashat-Cruz, M., randa-Patron, E., Leon, A.R., Justiniani, N., Perez-Ricardez, L., vila-Cortes, F., Castelan, M., Becerril, R., and Herrera, E.L. 1999. Prevalence of nosocomial infections in children: survey of 21 hospitals in Mexico. Salud Publica Mex. 41 Suppl 1: S18–S25.
Vincent, J.L., Brun-Buisson, C., Niederman, M., Haenni, C., Harbarth, S., Sprumont, D., Valencia, M., and Torres, A. 2005. Ethics roundtable debate: a patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus – how do you defend your case and your team? Crit Care 9: 5–9.
Wertheimer, A.I. and Santella, T.M. 2007. Innovation and the WHO's essential medicines list: giving credit where credit is due. Res. Social. Adm Pharm. 3: 137–144.
WHO and UNICEF. Management of the child with a serious illness or severe malnutrition. Guidelines for care at the first referral level in developing countries. WHO/FCH/CAH/00.1.2000. Geneva: World Health Organization, 2000.
Yalcin, A.N. 2003. Socioeconomic burden of nosocomial infections. Indian J. Med. Sci. 57: 450–456.
Yang, K.S., Fong, Y.T., Lee, H.Y., Kurup, A., Koh, T.H., Koh, D., and Lim, M.K. 2007. Predictors of vancomycin-resistant enterococcus (VRE) carriage in the first major VRE outbreak in Singapore. Ann. Acad. Med. Singapore 36: 379–383.
Zaidi, A.K., Huskins, W.C., Thaver, D., Bhutta, Z.A., Abbas, Z., and Goldmann, D.A. 2005. Hospital-acquired neonatal infections in developing countries. Lancet 365: 1175–1188.
Zaidi, M., Angulo, M., and Sifuentes-Osornio, J. 1995. Disinfection and sterilization practices in Mexico. J. Hosp. Infect. 31: 25–32.
Zarate, M.S., Gales, A., Jorda-Vargas, L., Yahni, D., Relloso, S., Bonvehi, P., Monteiro, J., Campos-Pignatari, A., and Smayevsky, J. 2007. Environmental contamination during a vancomycin-resistant Enterococci outbreak at a hospital in Argentina. Enferm. Infecc. Microbiol. Clin. 25: 508–512.
Zavascki, A.P., Barth, A.L., Gaspareto, P.B., Goncalves, A.L., Moro, A.L., Fernandes, J.F., and Goldani, L.Z. 2006. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J. Antimicrob. Chemother. 58: 882–885.
Zubaidah, A.W., Ariza, A., and Azmi, S. 2006. Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital. Med. J. Malaysia 61: 487–489.
Acknowledgment
Dr. Fatima Mir received research training support from the National Institute of Health’s Fogarty International Center (1 D43 TW007585-01) which made this work possible.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mir, F., Zaidi, A.K.M. (2010). Hospital Infections by Antimicrobial-Resistant Organisms in Developing Countries. In: Sosa, A., Byarugaba, D., Amábile-Cuevas, C., Hsueh, PR., Kariuki, S., Okeke, I. (eds) Antimicrobial Resistance in Developing Countries. Springer, New York, NY. https://doi.org/10.1007/978-0-387-89370-9_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-89370-9_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-89369-3
Online ISBN: 978-0-387-89370-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)